Your browser doesn't support javascript.
loading
Immunogenicity and safety of SARS-CoV-2 vaccine in hemodialysis patients: A systematic review and meta-analysis.
Peiyao, Ren; Mengjie, Yu; Xiaogang, Shen; Wenfang, He; Danna, Zheng; Yuqun, Zeng; Juan, Jin; Qiang, He.
Affiliation
  • Peiyao R; Second Clinical Medical School, Zhejiang Chinese Medical University, Hangzhou, China.
  • Mengjie Y; Urology and Nephrology Center, Department of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
  • Xiaogang S; Urology and Nephrology Center, Department of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
  • Wenfang H; Department of Nephrology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China.
  • Danna Z; Urology and Nephrology Center, Department of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
  • Yuqun Z; Urology and Nephrology Center, Department of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
  • Juan J; Urology and Nephrology Center, Department of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
  • Qiang H; Urology and Nephrology Center, Department of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
Front Public Health ; 10: 951096, 2022.
Article de En | MEDLINE | ID: mdl-36211647

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins / COVID-19 Type d'étude: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limites: Humans Langue: En Journal: Front Public Health Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Suisse

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins / COVID-19 Type d'étude: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limites: Humans Langue: En Journal: Front Public Health Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Suisse